FDA
approval
· 2022-02-17
FDA Approved: VALGANCICLOVIR — Original Application (airis PHARMA PVT LTD)
Summary
FDA approves the original application for valganciclovir from airis PHARMA PVT LTD, enabling a generic version of the antiviral for cytomegalovirus (CMV) infect…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VALGANCICLOVIR (VALGANCICLOVIR)